HK-listed YiChang HEC rises most in 3 months on robust sales outlook

62
9
Favorite

HK-listed YiChang HEC rises most in 3 months on robust sales outlook

Reuters2021-06-25

** Shares of YiChang HEC ChangJiang Pharmaceutical Co Ltd rise as much as 10.9% to HK$7.94, the biggest intraday percentage gain since March 22

** Stock hits its highest since April 30; among the 30 biggest percentage gainers on the Hong Kong bourse

** Company based in central province of Hubei says its newly acquired aripiprazole and rivaroxaban tablets won bid for centralised procurement, and sales volumes are set to increase significantly

** Says improved income structure will have a positive impact on future operating performance

** The Hong Kong Hang Seng Commerce & Industry Index rises 1.5%

** The Hang Seng China Enterprises Index climbs 1.4% and the benchmark index gains 1.1%

** By last close, the stock had fallen 18.9% this year

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（9）

KHW
·2021-06-25
Good
Reply
Like
Report
THong
·2021-06-25
Nice ..however it is a downtrending chart..hopefully it can pick-up soon.
Reply
1
Report
fionacheng
·2021-06-25
Yooo
Reply
2
Report
GoG
·2021-06-25
Ok
Reply
1
Report
Fold Replies
- Leo_T:
  yes
  2021-06-25
  Reply
  Report
KKYONG
·2021-06-25
Great
Reply
2
Report
T0000024852
·2021-06-25
Hi
Reply
5
Report
CaptainLai
·2021-06-25
Well done.
Reply
5
Report
Fold Replies
- T0000024852:
  Nice
  2021-06-25
  Reply
  Report
Jggggtjg
·2021-06-25
.
Reply
4
Report
Razak
·2021-06-25
Thank you
Reply
5
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2146088024?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-25 13:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2146088024","market":"hk","top_or_hot":-1,"title":"HK-listed YiChang HEC rises most in 3 months on robust sales outlook","media":"Reuters","content":"<p>** Shares of YiChang HEC ChangJiang Pharmaceutical Co Ltd&nbsp;rise as much as 10.9% to HK$7.94, the biggest intraday percentage gain since March 22</p>\n<p>** Stock hits its highest since April 30; among the 30 biggest percentage gainers on the Hong Kong bourse</p>\n<p>** Company based in central province of Hubei says its newly acquired aripiprazole and rivaroxaban tablets won bid for centralised procurement, and sales volumes are set to increase significantly</p>\n<p>** Says improved income structure will have a positive impact on future operating performance</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index rises 1.5%</p>\n<p>** The Hang Seng China Enterprises Index climbs 1.4%&nbsp;and the benchmark index gains 1.1%</p>\n<p>** By last close, the stock had fallen 18.9% this year</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed YiChang HEC rises most in 3 months on robust sales outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed YiChang HEC rises most in 3 months on robust sales outlook\n</h2>\n\n<h4 class=\"meta\">\n\n2021-06-25 13:13 北京时间&nbsp;&nbsp;&nbsp;<strong>Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>** Shares of YiChang HEC ChangJiang Pharmaceutical Co Ltd rise as much as 10.9% to HK$7.94, the biggest intraday percentage gain since March 22\n** Stock hits its highest since April 30; among the 30 ...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01558","symbol_name":"东阳光长江药业","start_time":0,"source_url":null,"article_id":"2146088024","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2146088024","pubTimestamp":1624598032,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** Shares of YiChang HEC ChangJiang Pharmaceutical Co Ltd rise as much as 10.9% to HK$7.94, the bigg","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"01558":"东阳光长江药业"},"translate_title":"香港上市宜昌港灯3个月来涨幅最大销售前景强劲","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01558":0.9},"content_text":"** Shares of YiChang HEC ChangJiang Pharmaceutical Co Ltd rise as much as 10.9% to HK$7.94, the biggest intraday percentage gain since March 22\n** Stock hits its highest since April 30; among the 30 biggest percentage gainers on the Hong Kong bourse\n** Company based in central province of Hubei says its newly acquired aripiprazole and rivaroxaban tablets won bid for centralised procurement, and sales volumes are set to increase significantly\n** Says improved income structure will have a positive impact on future operating performance\n** The Hong Kong Hang Seng Commerce & Industry Index rises 1.5%\n** The Hang Seng China Enterprises Index climbs 1.4% and the benchmark index gains 1.1%\n** By last close, the stock had fallen 18.9% this year","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":122187621,"gmtCreate":1624604606963,"gmtModify":1703841532216,"author":{"id":"3586261606500608","authorId":"3586261606500608","name":"KHW","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586261606500608","authorIdStr":"3586261606500608"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/122187621","repostId":2146088024,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122133740,"gmtCreate":1624602560780,"gmtModify":1703841494794,"author":{"id":"3580966282271442","authorId":"3580966282271442","name":"THong","avatar":"https://static.tigerbbs.com/e78a561ce206344f844e5f373dd72ec3","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3580966282271442","authorIdStr":"3580966282271442"},"htmlText":"Nice ..however it is a downtrending chart..hopefully it can pick-up soon.","listText":"Nice ..however it is a downtrending chart..hopefully it can pick-up soon.","text":"Nice ..however it is a downtrending chart..hopefully it can pick-up soon.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/122133740","repostId":2146088024,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122101639,"gmtCreate":1624601287521,"gmtModify":1703841469178,"author":{"id":"3580357526223185","authorId":"3580357526223185","name":"fionacheng","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":0,"idStr":"3580357526223185","authorIdStr":"3580357526223185"},"htmlText":"Yooo","listText":"Yooo","text":"Yooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/122101639","repostId":2146088024,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122378490,"gmtCreate":1624600741210,"gmtModify":1703841457355,"author":{"id":"3570186020309805","authorId":"3570186020309805","name":"GoG","avatar":"https://static.tigerbbs.com/1c9fbe31d027bcf439a17955df60352f","vip":1,"hat":"https://static.tigerbbs.com/646756f1284a5a6480ed02cc4fa7d1d2","crmLevel":7,"crmLevelSwitch":1,"idStr":"3570186020309805","authorIdStr":"3570186020309805"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/122378490","repostId":2146088024,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5009743,"gmtCreate":1624600939023,"gmtModify":1663229980233,"authorId":3577164655493669,"author":{"id":3577164655493669,"idStr":"3577164655493669","authorId":3577164655493669,"name":"Leo_T","avatar":"https://static.tigerbbs.com/4639e7c3fcdc38b65d6833798171bf2d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":122378490,"type":1,"supId":0,"prevId":0,"content":"<u>yes</u>","text":"<u>yes</u>","html":"<u>yes</u>"}],"langContent":"EN"},{"id":122351503,"gmtCreate":1624599277202,"gmtModify":1703841427005,"author":{"id":"4087700861998360","authorId":"4087700861998360","name":"KKYONG","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4087700861998360","authorIdStr":"4087700861998360"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/122351503","repostId":2146088024,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122322656,"gmtCreate":1624598922975,"gmtModify":1703841417234,"author":{"id":"3586426272011868","authorId":"3586426272011868","name":"T0000024852","avatar":"https://static.tigerbbs.com/558c2124ff14f2c3586c97422ed4a346","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586426272011868","authorIdStr":"3586426272011868"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/122322656","repostId":2146088024,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122328193,"gmtCreate":1624598795212,"gmtModify":1703841414143,"author":{"id":"3568077469165848","authorId":"3568077469165848","name":"CaptainLai","avatar":"https://static.tigerbbs.com/29e2b12a30bd14fc69d3e4bd1c61b4f4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3568077469165848","authorIdStr":"3568077469165848"},"htmlText":"Well done.&nbsp;","listText":"Well done.&nbsp;","text":"Well done.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/122328193","repostId":2146088024,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5009399,"gmtCreate":1624598912274,"gmtModify":1663229981450,"authorId":3586426272011868,"author":{"id":3586426272011868,"idStr":"3586426272011868","authorId":3586426272011868,"name":"T0000024852","avatar":"https://static.tigerbbs.com/558c2124ff14f2c3586c97422ed4a346","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":122328193,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"}],"langContent":"EN"},{"id":122321690,"gmtCreate":1624598743810,"gmtModify":1703841413002,"author":{"id":"3584967080149000","authorId":"3584967080149000","name":"Jggggtjg","avatar":"https://static.tigerbbs.com/d44a6c7cca471293970e3a6ac785b580","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3584967080149000","authorIdStr":"3584967080149000"},"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/122321690","repostId":2146088024,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122368789,"gmtCreate":1624598188441,"gmtModify":1703841400596,"author":{"id":"3577134043689710","authorId":"3577134043689710","name":"Razak","avatar":"https://static.tigerbbs.com/fb3aaeddad6ac1bdd8da9f5841c37524","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3577134043689710","authorIdStr":"3577134043689710"},"htmlText":"Thank you","listText":"Thank you","text":"Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/122368789","repostId":2146088024,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":62,"commentSize":9,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}